Rachel Harding

Dr. Rachel Harding

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2018 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
PDF file
RHRachel Harding
Rachel Harding
YTYufeng Tong
Yufeng Tong

9 May 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RFRenato Ferreira de Freitas
Renato Ferreira de Freitas
RHRachel Harding
Rachel Harding
IFIvan Franzoni
Ivan Franzoni
MRMani Ravichandran
Mani Ravichandran
MMMandeep K. Mann
Mandeep K. Mann
MSMatthieu Schapira
Matthieu Schapira

8 December 2021 in Communications Biology
Verified
Journal Article
Open access
PDF file
RHRachel Harding
Rachel Harding
JDJustin C. Deme
Justin C. Deme
JHJohannes F. Hevler
Johannes F. Hevler
STSem Tamara
Sem Tamara
ALAlexander Lemak
Alexander Lemak
CACheryl H. Arrowsmith
Cheryl H. Arrowsmith
Huntington’s disease results from expansion of a glutamine-coding CAG tract in the huntingtin (HTT) gene, producing an aberrantly functioning form of HTT. Both wildtype and disease-state HTT form a hetero-dimer with HAP40 of unknown functional relevance. We demonstrate in vivo and in cell models that HTT and HAP40 cellular abundance are coupled. Integrating data from a 2.6 Å cryo-electron microscopy structure, cross-linking mass spectrometry, small-angle X-ray scattering, and modeling, we provide a near-atomic-level view of HTT, its molecular interaction surfaces and compacted domain architecture, orchestrated by HAP40. Native mass spectrometry reveals a remarkably stable hetero-dimer, potentially explaining the cellular inter-dependence of HTT and HAP40. The exon 1 region of HTT is dynamic but shows greater conformational variety in the polyglutamine expanded mutant than wildtype exon 1. Our data provide a foundation for future functional and drug discovery studies targeting Huntington’s disease and illuminate the structural consequences of HTT polyglutamine expansion.

5 November 2024 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
FLFengling Li
Fengling Li
SASuzanne Ackloo
Suzanne Ackloo
CACheryl H. Arrowsmith
Cheryl H. Arrowsmith
FBFuqiang Ban
Fuqiang Ban
CBChristopher J. Barden
Christopher J. Barden
MSMatthieu Schapira
Matthieu Schapira

27 October 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RHRachel Harding
Rachel Harding
RFRenato Ferreira de Freitas
Renato Ferreira de Freitas
PCPatrick Collins
Patrick Collins
IFIvan Franzoni
Ivan Franzoni
MRMani Ravichandran
Mani Ravichandran
CACheryl H. Arrowsmith
Cheryl H. Arrowsmith

1 April 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
RHRachel Harding
Rachel Harding
PLPeter Loppnau
Peter Loppnau
SASuzanne Ackloo
Suzanne Ackloo
ALAlexander Lemak
Alexander Lemak
AHAshley Hutchinson
Ashley Hutchinson
CACheryl H. Arrowsmith
Cheryl H. Arrowsmith
The gene mutated in individuals with Huntington's disease (HD) encodes the 348-kDa huntingtin (HTT) protein. Pathogenic HD CAG-expansion mutations create a polyglutamine (polyQ) tract at the N terminus of HTT that expands above a critical threshold of ∼35 glutamine residues. The effect of these HD mutations on HTT is not well understood, in part because it is difficult to carry out biochemical, biophysical, and structural studies of this large protein. To facilitate such studies, here we have generated expression constructs for the scalable production of HTT in multiple eukaryotic expression systems. Our set of HTT expression clones comprised both N- and C-terminally FLAG-tagged HTT constructs with polyQ lengths representative of the general population, HD patients, and juvenile HD patients, as well as the more extreme polyQ expansions used in some HD tissue and animal models. Our expression system yielded milligram quantities of pure recombinant HTT protein, including many of the previously mapped post-translational modifications. We characterized both apo and HTT–HTT-associated protein 40 (HAP40) complex samples produced with this HD resource, demonstrating that this toolkit can be used to generate physiologically meaningful HTT complexes. We further demonstrate that these resources can produce sufficient material for protein-intensive experiments, such as small-angle X-ray scattering, providing biochemical insight into full-length HTT protein structure. The work outlined and the tools generated here lay a foundation for further biochemical and structural work on the HTT protein and for studying its functional interactions with other biomolecules.